|
Mefoxin In Sodium Chloride 0.9% In Plastic ContainerDrug - Mefoxin In Sodium Chloride 0.9% In Plastic Container The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Cefoxitin Sodium
Strength -
EQ 20MG BASE/ML
Applicant -
MERCK
New Drug Application (NDA) Number -
050581
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 20, 1984
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Merck And Co Inc
Mefoxin In Sodium Chloride 0.9% In Plastic Container
Mefoxin Eq 1gm Base/vial Injectable; Injection
Mefoxin Eq 1gm Base/vial Injectable; Injection Mefoxin Eq 2gm Base/vial Injectable; Injection Mefoxin Eq 2gm Base/vial Injectable; Injection Mefoxin In Dextrose 5% In Plastic Container Eq 20mg Base/ml Injectable; Injection Mefoxin In Dextrose 5% In Plastic Container Eq 40mg Base/ml Injectable; Injection Mefoxin In Plastic Container Eq 20mg Base/ml Injectable; Injection Mefoxin In Plastic Container Eq 40mg Base/ml Injectable; Injection Mefoxin In Sodium Chloride 0.9% In Plastic Container Eq 20mg Base/ml Injectable; Injection Mefoxin Eq 10gm Base/vial Injectable; Injection NewDrugInformation |